Inventor

DJURIC STEVAN W

US57 patents

⚠️ This page may combine multiple inventors who share the name “DJURIC STEVAN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DJURIC STEVAN W

SEARLE & CO

Leukotriene B4 antagonists

LTA4 Hydrolase inhibitors

Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof

Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives

Leukotriene B4 synthesis inhibitors

LTB4 synthesis inhibitors

Phenylene, furyl, and thienyl leukotriene B4 analogues

Leukotriene B4 antagonists

Leukotriene b4 antagonists

PLA2 inhibitors as antiinflammatories

Substituted N-benzyl-4-(benzhydryl) piperidines

Anti-inflammatory compounds, compositions and method of use thereof

LTB4 synthesis inhibitors

LTB4 synthesis inhibitors

Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof

Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof

LTB4 synthesis inhibitors

Ltb4 synthesis inhibitors

Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use

Allenic prostacyclins

Leukotriene B4 antagonists

Furyl, phenylene, and thienyl leukotriene B4 analogues

Furyl, phenylene, and thienyl leukotriene B4 analogues

5-fluoro-3-oxa-prostacyclin compounds

5-fluoro-3-oxa-6,7-didehydro-PGI1 compounds

LTB4 synthesis inhibitors

Furyl, phenylene, and thienyl leukotriene B4 analogues

1,3-dioxolane derivatives useful in the treatment of inflammation

Allenic prostacyclins

15(R)-5-fluoroprostacyclins, pharmaceutical compositions and anti-thrombotic methods of use thereof

15(R)-5-fluoroprostacyclins, pharmaceutical compositions and anti-thrombotic method of use thereof

ABBOTT LAB

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

Oxazolidinone chemotherapeutic agents

9-amino erythromycin derivatives with antibacterial activity

Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

Tricyclic pyrazole kinase inhibitors

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)

Oxazolidinone chemotherapeutic agents

ABBVIE DEUTSCHLAND

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

Modulators of 5-HT receptors and methods of use thereof

Modulators of 5-HT receptors and methods of use thereof

WANG YING

Modulators of 5-HT receptors and methods of use thereof

Modulators of 5-HT receptors and methods of use thereof

AKRITOPOULOU-ZANZE IRINI

5-substituted indazoles as kinase inhibitors

RHONE POULENC RORER PHARMA

Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds

ABBVIE INC

5-substituted indazoles as kinase inhibitors

C D SEARLE & CO

Phenylene, furyl, and thienyl leukotriene B4 analogues

MADAR DAVID J

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)